Reed Joshua 4
4 · Aldeyra Therapeutics, Inc. · Filed Apr 1, 2022
Insider Transaction Report
Form 4
Reed Joshua
Chief Financial Officer
Transactions
- Award
Common Stock
2022-03-30+93,322→ 274,825 total - Award
Employee Stock Option (Right to Buy)
2022-03-30+250,000→ 250,000 totalExercise: $4.52Exp: 2032-03-29→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
- [F2]Includes 8,022 shares previously purchased under the Issuer's Employee Stock Purchase Plan.
- [F3]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2022.